Liver Biopsy Market size was valued at USD 5160 million in 2022, and is estimate to reach USD 8539 million by 2030, with growing CAGR of 6.5% over the forecast period 2023-2030.
The Liver Biopsy Market Report provides a comprehensive analysis of the global Liver Biopsy market, highlighting key trends, growth drivers, challenges, and opportunities. The report aims to assist industry stakeholders in making informed decisions and formulating effective strategies.
The liver biopsy market is expected to witness significant growth in the coming years due to various factors. One of the key drivers is the increasing prevalence of liver diseases worldwide. Liver diseases, such as hepatitis, cirrhosis, and fatty liver disease, are on the rise due to factors like unhealthy lifestyles, alcohol consumption, and viral infections.
Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2796
Liver biopsy plays a crucial role in diagnosing and monitoring these liver diseases. It involves the removal of a small tissue sample from the liver for microscopic examination. This procedure helps in determining the extent of liver damage, identifying the underlying cause of disease, and guiding appropriate treatment decisions.
With advancements in technology, there has been a shift towards minimally invasive techniques for liver biopsy. Traditional methods like percutaneous biopsy are being replaced by image-guided procedures such as ultrasound-guided or CT-guided biopsies. These techniques offer improved accuracy, reduced complications, and faster recovery times for patients.
KEY MARKET SEGMENTS
- Percutaneous Biopsy
- Trans jugular Biopsy
- Laparoscopic Biopsy
- Robotic Biopsy
- Clinics and Ambulatory Surgical Centers
- Research and Academic Institutes
- Liver Cirrhosis
- Liver Cancer
- Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
- Other Liver Diseases
- Conventional Biopsy Needles:
- Vacuum-Assisted Biopsy Systems
- Image-Guided Biopsy
- Other Emerging Technologies
Major Players Listed in the Report are as Follows:
Becton, Dickinson and Company (BD), Cook Medical, Medtronic placebos Scientific Corporation, Olympus Corporation, Veran Medical Technologies, Angiotech Pharmaceuticals, TSK Laboratory, Cardinal Health, SOMATEX Medical Technologies, Argon Medical Devices, Med axiom Corporation, Merit Medical Systems, Path Group & Other Players
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Akash Anand – Head of Business Development & Strategy,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)